How many employees work at Evommune?
Evommune, Inc. (EVMN) has approximately 52 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Evommune’s total headcount has grown 41.2% from 37 employees in 2023 to 52 in 2026.
Is Evommune hiring right now?
No, Evommune is not actively hiring. Evommune had 0 active job postings in 2026, a 0.0% no change from 2025 — see job openings & hiring trends.
About Evommune’s Workforce
Evommune, Inc. (EVMN) is a Biotech and Healthcare Services company that employs 52 people worldwide as of March 2026. It is the 8th-largest by headcount among its peers. Founded in 2020, the company is headquartered in Palo Alto, California and trades on the New York Stock Exchange.
Evommune's workforce has grown 41.2% from 2023 to 2026, though it is down 1.6% year over year in 2026. It fell to a low of 33 in 2023 Q4 before recovering. Its workforce is concentrated most in North America (95.6%), followed by Northern Europe (2.7%) and Western Europe (1.7%).
Evommune's functional groups are Finance and Operations (59.5%), Engineering (22.4%), and Sales and Marketing (18.1%), with Sales and Marketing growing fastest (up 8.0%). The average salary is $185,937, highest in North America at a median of $196,000, up 3.0% year over year in 2026.
Evommune's hiring activity held steady in 2026. Overall employee sentiment is positive and broadly stable.
Sourced from Revelio Labs workforce data.
- Ticker
- New York Stock Exchange: EVMN
- Headquarters
- Palo Alto, California
- Founded
- 2020
- Industry
- Biotech and Healthcare Services
- Employees
- 52
- YoY
- -1.6% (+3)
As of March 2026
Evommune workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Evommune. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsEvommune Annual Employee Count (2023-2026)
- Evommune had 52 employees in 2026, a 1.6% decline (+3) from 2025.
- Evommune had 47 employees in 2025, a 1.9% decline (+3) from 2024.
- Evommune had 44 employees in 2024, a 3.5% increase (+11) from 2023.
- Evommune had 33 employees in 2023, a 13.5% increase (+7) from 2022.
Evommune's total workforce has grown from 37 employees in 2023 to 52 in 2026.
Evommune, Inc. quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 52 | +3 | -1.6% |
| 2025 | Q4 | 47 | +3 | -1.9% |
| 2025 | Q3 | 47 | +3 | -2.0% |
| 2025 | Q2 | 54 | +4 | +1.1% |
| 2025 | Q1 | 49 | +9 | +3.3% |
| 2024 | Q4 | 44 | +11 | +3.5% |
| 2024 | Q3 | 44 | +8 | -0.1% |
| 2024 | Q2 | 50 | +13 | +3.5% |
| 2024 | Q1 | 40 | +13 | +14.9% |
| 2023 | Q4 | 33 | +7 | +13.5% |
| 2023 | Q3 | 36 | +11 | +17.8% |
| 2023 | Q2 | 37 | +14 | +16.1% |
See Evommune's complete headcount history, including quarterly breakdowns.
Get the DataEvommune Employee Count by Region (2026)
North America accounts for the largest share of Evommune's global workforce with approximately 96% of total employees, followed by Northern Europe and Western Europe.
Evommune employees by region
| Region | Employees | % of Total |
|---|---|---|
| North America | 48 | 95.6% |
| Northern Europe | 1 | 2.7% |
| Western Europe | 1 | 1.7% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataEvommune Employee Count by Department (2026)
Evommune's employee groups are Finance and Operations (59.5%), Engineering (22.4%), and Sales and Marketing (18.1%).
Evommune employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 31 | 59.5% |
| Engineering | 12 | 22.4% |
| Sales and Marketing | 9 | 18.1% |
Compare Evommune's department mix to industry peers.
See Full DataEvommune Employee Salary by Region (2026)
Evommune's average employee salary is $185,937 globally. Employees in North America receive the highest compensation.
Evommune median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| North America | $196,000 |
Unlock salary by role, level, and city — and compare to Evommune's industry peers.
Unlock Salary DataEvommune Job Openings and Hiring Trends (2023-2026)
- Evommune had 0 active job postings in 2026, a 0% no change (-2) from 2025.
- Evommune had 2 active job postings in 2025, a 200.0% increase (+2) from 2024.
- Evommune had 0 active job postings in 2024, a 200.0% decline (-1) from 2023.
- Evommune had 1 active job postings in 2023, a 66.7% decline from 2022.
- Hiring velocity in 2026: 0 new roles/month, down from 1 in 2025 and 1 in 2024.
Evommune's hiring activity held steady in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataEvommune Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across Evommune's workforce based on public professional data. Overall sentiment is positive and has held steady year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Similar Biotech and Healthcare Services Companies by Employee Count
Frequently Asked Questions About Evommune
- How fast is Evommune growing?
- In 2026, Evommune's headcount shrank 1.6% to 52 employees, up from 49 in 2025.
- See the full headcount history
- Where are Evommune employees located?
- Most Evommune employees are based in North America (95.6% of headcount), followed by Northern Europe and Western Europe.
- Explore where the workforce is based
- What is the average salary at Evommune?
- The average employee salary at Evommune is approximately $185.9k per year.
- Analyze the salary distribution
- How many new job postings does Evommune open per year?
- In Q1 2026, Evommune opened 0 new job postings. In 2025, Evommune opened 9 new job postings — about 1 per month.
- Track hiring trends by role
- When was Evommune founded and where is it headquartered?
- Evommune was founded in 2020 and is headquartered in Palo Alto, California.
- Compare Evommune to industry peers
Speak with a workforce expert about Evommune.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.